Immunotherapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.3 | Q3 | 26.8% | 0.666 | Q3 | 71.2% |
| 2024 | 2.3 | Q3 | 28.3% | 0.835 | Q2 | 79.2% |
| 2023 | 2.7 | Q3 | 31.6% | 0.690 | Q2 | 75.2% |
| 2022 | 2.8 | Q4 | 32.3% | 0.798 | Q2 | 80.4% |
| 2021 | 4.0 | Q3 | 43.8% | 0.821 | Q2 | 81.8% |
| 2020 | — | — | 1.127 | Q2 | 87.7% | |
| 2019 | — | — | 0.963 | Q2 | 84.8% | |
| 2018 | — | — | 1.062 | Q2 | 85.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1750-7448
ISSN
1750-743X
country
GBcoverage
2009-2026